Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
708 (USA) · Dr. Kim
consented 2013-05-09
Adverse events
Mild DIZZINESS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-23 (study day 15.0); relationship: POSSIBLE
Mild DIZZINESS — outcome: RECOVERED/RESOLVED; onset 2013-05-23 (study day 15.0); relationship: POSSIBLE
Mild MYOCARDIAL INFARCTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-09 (study day 32.0); relationship: REMOTE
Mild MYOCARDIAL INFARCTION — outcome: RECOVERED/RESOLVED; onset 2013-06-09 (study day 32.0); relationship: REMOTE
Mild SINUS BRADYCARDIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-23 (study day 46.0); relationship: REMOTE
Mild SINUS BRADYCARDIA — outcome: RECOVERED/RESOLVED; onset 2013-06-23 (study day 46.0); relationship: REMOTE
Data queries
No data queries.